In this review, we systematically summarized the latest advances in developing inorganic chelators and metal complexes as anti-cancer agents through regulating intracellular ROS levels, with a particular focus on those targeting mitochondria and antioxidant enzyme systems, including SOD1, TrxR, and CAT. The gene discussed is CAT; the disease is cancer.